Laddar...
Comparing Biomarkers as Trial Level General Surrogates
An intermediate response measure that accurately predicts efficacy in a new setting can reduce trial cost and time to product licensure. In this paper, we define a trial level general surrogate, which is an intermediate response that can be used to accurately predict efficacy in a new setting. Metho...
Sparad:
| I publikationen: | Biometrics |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5045774/ https://ncbi.nlm.nih.gov/pubmed/27038302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/biom.12513 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|